# Concomitant Chemoradiotherapy (CCRT) With Weekly Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer

> **NCT01126008** · PHASE2 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 44 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** CCRT with weekly docetaxel & cisplatin

## Key facts

- **NCT ID:** NCT01126008
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11-16
- **Primary completion:** 2016-04-15
- **Final completion:** 2016-04-15
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2021-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01126008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01126008, "Concomitant Chemoradiotherapy (CCRT) With Weekly Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01126008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*